Sophie Nadaud
Paris, 75013, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
FABP4&5: another brick in the lipid road of pulmonary arterial hypertension?
Journal: American journal of respiratory cell and molecular biology
Published: July 24, 2025
T-cell dysregulation and inflammatory process in Gcn2 (Eif2ak4-/-)-deficient rats in basal and stress conditions.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: February 28, 2023
Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis.
Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis.
Journal: American journal of respiratory cell and molecular biology
Published: December 08, 2022
The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
Journal: Life (Basel, Switzerland)
Published: April 14, 2022
Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.
Journal: Journal of the American Heart Association
Published: March 29, 2022
Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 29, 2021
Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension.
Journal: Cells
Published: April 28, 2021
Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure.
Journal: Scientific reports
Published: January 18, 2021
Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
Journal: American journal of respiratory cell and molecular biology
Published: March 27, 2020
Last Updated: 09/26/2026